google-site-verification: googlec7193c3de77668c9.html

Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome

[
The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome (LS), according to a study from researchers at The University of Texas MD Anderson Cancer Center.


Source link

Advertisements
Views: 0

See also  Simple ways to reduce inflammation and protect your heart

Check Also

Structured lifestyle programs may help slow aging in older adults, study finds

[ Researchers at Wake Forest University School of Medicine found evidence of slowed aging from …

New study shows drinking water filtration systems may add months to lifespan

[ As more than two billion people worldwide still lack access to safely managed drinking …

Very fit men may face smaller atrial fibrillation risk than feared, with heart benefits growing over time

[ Credit: Unsplash/CC0 Public Domain A number of previous studies have shown that young male …

Leave a Reply

Available for Amazon Prime